Abiopharma

🔍 WALL JOHN M (Executive)

Company: CADENCE DESIGN SYSTEMS INC (CDNS)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Sold 412 shares of Common Stock at $346.68 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 86,463.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,021 shares of Common Stock at $347.75 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 85,442.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,907 shares of Common Stock at $348.68 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 83,535.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,280 shares of Common Stock at $349.41 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 82,255.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 380 shares of Common Stock at $351.32 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 81,875.00 | transaction_form_type: 4 | Footnotes: F1, F6

Footnotes:

• F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted on 5/6/2025 by the Reporting Person.
• F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $346.16 to $347.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $347.175 to $348.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $348.18 to $349.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $349.21 to $349.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $350.955 to $351.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.